Movement Alert｜EVEREST MED Falls 6.17% in Regular Trading, Biotech Sector Retreat Weighs

Market Focus

Yesterday

On October 7, EVEREST MED fell 6.17% in regular trading, trading at HK$28.24 with turnover of HK$154.86 million.

The decline came amid broad weakness across the biotechnology sector, with peers CANSINOBIO down 6.5%, 3SBIO down 2.81%, INNOVENT BIO down 2.26%, AKESO down 1.9%, and BEONE MEDICINES down 1.72%. Sector-wide profit-taking and sentiment-driven selling pressure weighed on the stock despite recent positive catalysts including an analyst upgrade to Buy and strong first-half revenue from its core product Tarpeyo.

Everest Medicines is a biopharmaceutical company focused on R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines across nephrology, anti-infectives, and autoimmune diseases. Its product portfolio includes Tarpeyo for kidney disease and Xerava for multidrug-resistant infections.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1167513813"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1167513813\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1167513813?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-07 09:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167513813","market":"hk","top_or_hot":-1,"title":"Movement Alert｜EVEREST MED Falls 6.17% in Regular Trading, Biotech Sector Retreat Weighs","media":"Market Focus","content":"<p><p>On October 7, EVEREST MED fell 6.17% in regular trading, trading at HK$28.24 with turnover of HK$154.86 million.</p><p>The decline came amid broad weakness across the biotechnology sector, with peers CANSINOBIO down 6.5%, 3SBIO down 2.81%, INNOVENT BIO down 2.26%, AKESO down 1.9%, and BEONE MEDICINES down 1.72%. Sector-wide profit-taking and sentiment-driven selling pressure weighed on the stock despite recent positive catalysts including an analyst upgrade to Buy and strong first-half revenue from its core product Tarpeyo.</p><p>Everest Medicines is a biopharmaceutical company focused on R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines across nephrology, anti-infectives, and autoimmune diseases. Its product portfolio includes Tarpeyo for kidney disease and Xerava for multidrug-resistant infections.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜EVEREST MED Falls 6.17% in Regular Trading, Biotech Sector Retreat Weighs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜EVEREST MED Falls 6.17% in Regular Trading, Biotech Sector Retreat Weighs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-07 09:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 7, EVEREST MED fell 6.17% in regular trading, trading at HK$28.24 with turnover of HK$154.86 million.</p><p>The decline came amid broad weakness across the biotechnology sector, with peers CANSINOBIO down 6.5%, 3SBIO down 2.81%, INNOVENT BIO down 2.26%, AKESO down 1.9%, and BEONE MEDICINES down 1.72%. Sector-wide profit-taking and sentiment-driven selling pressure weighed on the stock despite recent positive catalysts including an analyst upgrade to Buy and strong first-half revenue from its core product Tarpeyo.</p><p>Everest Medicines is a biopharmaceutical company focused on R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines across nephrology, anti-infectives, and autoimmune diseases. Its product portfolio includes Tarpeyo for kidney disease and Xerava for multidrug-resistant infections.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1167513813","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167513813","pubTimestamp":1791336924,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 7, EVEREST MED fell 6.17% in regular trading, trading at HK$28.24 with turnover of HK$154.86 million.The decline came amid broad weakness across the biotechnology sector, with peers...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"走势警报|EVEREST MED常规交易下跌6.17%，生物科技板块回调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"On October 7, EVEREST MED fell 6.17% in regular trading, trading at HK$28.24 with turnover of HK$154.86 million.The decline came amid broad weakness across the biotechnology sector, with peers CANSINOBIO down 6.5%, 3SBIO down 2.81%, INNOVENT BIO down 2.26%, AKESO down 1.9%, and BEONE MEDICINES down 1.72%. Sector-wide profit-taking and sentiment-driven selling pressure weighed on the stock despite recent positive catalysts including an analyst upgrade to Buy and strong first-half revenue from its core product Tarpeyo.Everest Medicines is a biopharmaceutical company focused on R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines across nephrology, anti-infectives, and autoimmune diseases. Its product portfolio includes Tarpeyo for kidney disease and Xerava for multidrug-resistant infections.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}